Abstract
Par-4 is a widely expressed leucine zipper protein that confers sensitization to apoptosis induced by exogenous insults. Because the expression of genes that promote apoptosis may be down-regulated during tumorigenesis, we sought to examine the expression of Par-4 in human tumors. We present here evidence that Par-4 protein levels were severely decreased in human renal cell carcinoma specimens relative to normal tubular cells. Replenishment of Par-4 protein levels in renal cell carcinoma cell lines conferred sensitivity to apoptosis. Because apoptosis may serve as a defense mechanism against malignant transformation or progression, decreased expression of Par-4 may contribute to the pathophysiology of renal cell carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berra E, Municio MM, Sanz L, Frutos S, Diaz-Meco MT and Moscot JM. . (1997) Mol. Cell. Biol. 17: 4346–4354.
Boghaert ER, Sells SF, Walid A-J, Collini P, Neil W, Weinstein M, Strange M and Rangnekar VM . 1997 Cell Growth Differ. 8: 881–890.
Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM and Glenn G. . 1995 Hum. Mutat. 5: 66–75.
Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerner MI, Zbar B, Affara NA, Ferguson-Smith MA and Maher ER. . 1994 Hum. Mol. Genet. 3: 1303–1308.
Diaz-Meco MT, Municio MM, Frutos S., Sanchez P, Lozano J, Sanz L and Moscat J. . 1996 Cell 86: 777–786.
Foster K, Prowse A, van der Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM and Maher ER. . 1994 Hum. Mol. Genet. 3: 2169–2173.
Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F and Duh FM. . 1994 Nat. Genet. 7: 85–90.
Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM and Mattson MP. . 1998 Nat. Med. (in press).
Iliopoulos O, Kibel A, Gray S and Kaelin WGJ. . 1995 Nat. Med. 1: 822–826.
Kerr JFR, Winterford CM and Harmon W. . 1994 Cancer 73: 2013.
Linehan WM, Lerman ML and Sbar B. . 1995 JAMA 273: 564–570.
Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT and Ferguson-Smith MA. . 1990 Quart. J. Med. 77: 1151–1163.
Pan H, Yin C and van Dyke T. . 1997 Cancer Surveys 29: 305–325.
Qiu G, Ahmed M, Sells S, Cookson M, Mohiuddin M, Weinstein M and Rangnekar VM. . Oncogene (in press).
Rangnekar VM. . 1998 Apoptosis 3: 61–66.
Sells SF, Wood DP, Barve SJ, Muthukumar S, Jacob RJ, Crist SC, Humphreys S and Rangnekar VM. . 1994 Cell Growth Differ. 5: 457–466.
Sells SF, Han S-S, Muthukkumar S, Maddiwar N, Johnstone R, Boghaert E, Gillis D, Liu G, Nair P, Monnig S, Collini P, Mattson MP, Sukhatme VP, Zimmer SG, Wood Jr, DP, McRoberts JW, Shi Y and Rangnekar VM. . 1997 Mol. Cell. Biol. 17: 3823–3832.
Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS and Linehan WM. . 1995 J. Urol. 154: 278–282.
Williams GT. . 1991 Cell 65: 1097–1098.
Wyllie AH. . 1992 Cancer Metast. Rev. 11: 95–103.
Acknowledgements
This work was supported by NIH grant CA60872 and Council for Tobacco Research-USA grant 3490 to VMR: NIH grant CA68258 to YS; and NIH grant DK44921 to VPS.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cook, J., Krishnan, S., Ananth, S. et al. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene 18, 1205–1208 (1999). https://doi.org/10.1038/sj.onc.1202416
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202416